The global Varicella Vaccine revenue was US$ 4174 million in 2022 and is forecast to a readjusted size of US$ 7104.7 million by 2029 with a CAGR of 7.8% during the forecast period (2023-2029).

and India Varicella Vaccine Market

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

In India, the Varicella Vaccine revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.

In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

This report focuses on global and India Varicella Vaccine market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Varicella Vaccine will continue to grow rapidly in the future.

Global Varicella Vaccine Scope and Market Size

Varicella Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Varicella Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Varicella Vaccine market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Varicella Vaccine Market Report

Report Metric	Details
Report Name	and India Varicella Vaccine Market
Forecasted market size in 2029	US$ 7104.7 million
CAGR	7.8%
Forecasted years	2023 - 2029
Segment by Type	Injection Freeze-Dried Powder
Segment by Application	Kids Injection Adults Injection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Varicella Vaccine Market size in 2029?

Ans: The and India Varicella Vaccine Market size in 2029 will be US$ 7104.7 million.

What is the and India Varicella Vaccine Market share by type?

Ans: In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%.

What is the and India Varicella Vaccine Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Varicella Vaccine Market report?

Ans: The main players in the and India Varicella Vaccine Market are Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken

What are the Application segmentation covered in the and India Varicella Vaccine Market report?

Ans: The Applications covered in the and India Varicella Vaccine Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the and India Varicella Vaccine Market report?

Ans: The Types covered in the and India Varicella Vaccine Market report are Injection, Freeze-Dried Powder

1 Study Coverage

1.1 Varicella Vaccine Product Introduction

1.2 Global Varicella Vaccine Outlook 2018 VS 2022 VS 2029

1.2.1 Global Varicella Vaccine Sales in US$ Million for the Year 2018-2029

1.2.2 Global Varicella Vaccine Sales in Volume for the Year 2018-2029

1.3 India Varicella Vaccine Outlook 2018 VS 2022 VS 2029

1.3.1 India Varicella Vaccine Sales in US$ Million for the Year 2018-2029

1.3.2 India Varicella Vaccine Sales in Volume for the Year 2018-2029

1.4 Varicella Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Varicella Vaccine in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Varicella Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Varicella Vaccine Market Dynamics

1.5.1 Varicella Vaccine Industry Trends

1.5.2 Varicella Vaccine Market Drivers

1.5.3 Varicella Vaccine Market Challenges

1.5.4 Varicella Vaccine Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Varicella Vaccine by Type

2.1 Varicella Vaccine Market Segment by Type

2.1.1 Injection

2.1.2 Freeze-Dried Powder

2.2 Global Varicella Vaccine Market Size by Type

2.2.1 Global Varicella Vaccine Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Varicella Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Varicella Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Varicella Vaccine Market Size by Type

2.3.1 India Varicella Vaccine Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Varicella Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Varicella Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Varicella Vaccine by Application

3.1 Varicella Vaccine Market Segment by Application

3.1.1 Kids Injection

3.1.2 Adults Injection

3.2 Global Varicella Vaccine Market Size by Application

3.2.1 Global Varicella Vaccine Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Varicella Vaccine Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Varicella Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Varicella Vaccine Market Size by Application

3.3.1 India Varicella Vaccine Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Varicella Vaccine Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Varicella Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Varicella Vaccine Competitor Landscape by Company

4.1 Global Varicella Vaccine Market Size by Company

4.1.1 Global Key Manufacturers of Varicella Vaccine, Ranked by Revenue (2022)

4.1.2 Global Varicella Vaccine Revenue by Manufacturer (2018-2023)

4.1.3 Global Varicella Vaccine Sales by Manufacturer (2018-2023)

4.1.4 Global Varicella Vaccine Price by Manufacturer (2018-2023)

4.2 Global Varicella Vaccine Concentration Ratio (CR)

4.2.1 Varicella Vaccine Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Varicella Vaccine in 2022

4.2.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Varicella Vaccine, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Varicella Vaccine, Product Offered and Application

4.5 Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Varicella Vaccine Market Size by Company

4.7.1 Key Players of Varicella Vaccine in India, Ranked by Revenue (2022)

4.7.2 India Varicella Vaccine Revenue by Players (2018-2023)

4.7.3 India Varicella Vaccine Sales by Players (2018-2023)

5 Global Varicella Vaccine Market Size by Region

5.1 Global Varicella Vaccine Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Varicella Vaccine Market Size in Volume by Region (2018-2029)

5.2.1 Global Varicella Vaccine Sales in Volume by Region: 2018-2023

5.2.2 Global Varicella Vaccine Sales in Volume Forecast by Region (2024-2029)

5.3 Global Varicella Vaccine Market Size in Value by Region (2018-2029)

5.3.1 Global Varicella Vaccine Sales in Value by Region: 2018-2023

5.3.2 Global Varicella Vaccine Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Varicella Vaccine Market Size YoY Growth 2018-2029

6.2 Americas Varicella Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Varicella Vaccine Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Varicella Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Varicella Vaccine Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Varicella Vaccine Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Varicella Vaccine Market Size YoY Growth 2018-2029

7.2 EMEA Varicella Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Varicella Vaccine Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Varicella Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Varicella Vaccine Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Varicella Vaccine Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Varicella Vaccine Market Size YoY Growth 2018-2029

8.2 China Varicella Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Varicella Vaccine Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Varicella Vaccine Market Size YoY Growth 2018-2029

9.2 APAC Varicella Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Varicella Vaccine Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Varicella Vaccine Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Varicella Vaccine Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Varicella Vaccine Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Merck

10.1.1 Merck Company Information

10.1.2 Merck Description and Business Overview

10.1.3 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Merck Varicella Vaccine Products Offered

10.1.5 Merck Recent Development

10.2 GSK

10.2.1 GSK Company Information

10.2.2 GSK Description and Business Overview

10.2.3 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.2.4 GSK Varicella Vaccine Products Offered

10.2.5 GSK Recent Development

10.3 Shanghai Institute

10.3.1 Shanghai Institute Company Information

10.3.2 Shanghai Institute Description and Business Overview

10.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Shanghai Institute Varicella Vaccine Products Offered

10.3.5 Shanghai Institute Recent Development

10.4 BCHT

10.4.1 BCHT Company Information

10.4.2 BCHT Description and Business Overview

10.4.3 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.4.4 BCHT Varicella Vaccine Products Offered

10.4.5 BCHT Recent Development

10.5 Changsheng

10.5.1 Changsheng Company Information

10.5.2 Changsheng Description and Business Overview

10.5.3 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Changsheng Varicella Vaccine Products Offered

10.5.5 Changsheng Recent Development

10.6 Keygen

10.6.1 Keygen Company Information

10.6.2 Keygen Description and Business Overview

10.6.3 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Keygen Varicella Vaccine Products Offered

10.6.5 Keygen Recent Development

10.7 Green Cross

10.7.1 Green Cross Company Information

10.7.2 Green Cross Description and Business Overview

10.7.3 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Green Cross Varicella Vaccine Products Offered

10.7.5 Green Cross Recent Development

10.8 Biken

10.8.1 Biken Company Information

10.8.2 Biken Description and Business Overview

10.8.3 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Biken Varicella Vaccine Products Offered

10.8.5 Biken Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Varicella Vaccine Industry Chain Analysis

11.2 Varicella Vaccine Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Varicella Vaccine Production Mode & Process

11.4 Varicella Vaccine Sales and Marketing

11.4.1 Varicella Vaccine Sales Channels

11.4.2 Varicella Vaccine Distributors

11.5 Varicella Vaccine Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Varicella Vaccine CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Varicella Vaccine Market Trends

Table 3. Varicella Vaccine Market Drivers

Table 4. Varicella Vaccine Market Challenges

Table 5. Varicella Vaccine Market Restraints

Table 6. Global Varicella Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Varicella Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Varicella Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Varicella Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Varicella Vaccine, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Varicella Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Varicella Vaccine Revenue Share by Manufacturer, 2018-2023

Table 13. Global Varicella Vaccine Sales by Manufacturer, (M Doses), 2018-2023

Table 14. Global Varicella Vaccine Sales Share by Manufacturer, 2018-2023

Table 15. Global Varicella Vaccine Price by Manufacturer (2018-2023) & (USD/Dose)

Table 16. Global Varicella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Varicella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2022)

Table 18. Global Key Manufacturers of Varicella Vaccine, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Varicella Vaccine, Product Offered and Application

Table 20. Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Varicella Vaccine in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Varicella Vaccine Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Varicella Vaccine Revenue Share by Players, (2018-2023)

Table 25. India Varicella Vaccine Sales by Players, (M Doses), (2018-2023)

Table 26. India Varicella Vaccine Sales Share by Players, (2018-2023)

Table 27. Global Varicella Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Varicella Vaccine Sales in Volume by Region (2018-2023) & (M Doses)

Table 29. Global Varicella Vaccine Sales in Volume Forecast by Region (2024-2029) & (M Doses)

Table 30. Global Varicella Vaccine Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Varicella Vaccine Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Varicella Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Varicella Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Varicella Vaccine Sales in Volume by Country (2018-2023) & (M Doses)

Table 36. Americas Varicella Vaccine Sales in Volume by Country (2024-2029) & (M Doses)

Table 37. EMEA Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Varicella Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Varicella Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Varicella Vaccine Sales in Volume by Country (2018-2023) & (M Doses)

Table 41. EMEA Varicella Vaccine Sales in Volume by Country (2024-2029) & (M Doses)

Table 42. APAC Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Varicella Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Varicella Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Varicella Vaccine Sales in Volume by Country (2018-2023) & (M Doses)

Table 46. APAC Varicella Vaccine Sales in Volume by Country (2024-2029) & (M Doses)

Table 47. Merck Company Information

Table 48. Merck Description and Business Overview

Table 49. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 50. Merck Varicella Vaccine Product

Table 51. Merck Recent Development

Table 52. GSK Company Information

Table 53. GSK Description and Business Overview

Table 54. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 55. GSK Varicella Vaccine Product

Table 56. GSK Recent Development

Table 57. Shanghai Institute Company Information

Table 58. Shanghai Institute Description and Business Overview

Table 59. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 60. Shanghai Institute Varicella Vaccine Product

Table 61. Shanghai Institute Recent Development

Table 62. BCHT Company Information

Table 63. BCHT Description and Business Overview

Table 64. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 65. BCHT Varicella Vaccine Product

Table 66. BCHT Recent Development

Table 67. Changsheng Company Information

Table 68. Changsheng Description and Business Overview

Table 69. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 70. Changsheng Varicella Vaccine Product

Table 71. Changsheng Recent Development

Table 72. Keygen Company Information

Table 73. Keygen Description and Business Overview

Table 74. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 75. Keygen Varicella Vaccine Product

Table 76. Keygen Recent Development

Table 77. Green Cross Company Information

Table 78. Green Cross Description and Business Overview

Table 79. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 80. Green Cross Varicella Vaccine Product

Table 81. Green Cross Recent Development

Table 82. Biken Company Information

Table 83. Biken Description and Business Overview

Table 84. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 85. Biken Varicella Vaccine Product

Table 86. Biken Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Varicella Vaccine Customers List

Table 90. Varicella Vaccine Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Varicella Vaccine Product Picture

Figure 2. Global Varicella Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Varicella Vaccine Market Size 2018-2029 (US$ Million)

Figure 4. Global Varicella Vaccine Sales 2018-2029 (M Doses)

Figure 5. India Varicella Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Varicella Vaccine Market Size 2018-2029 (US$ Million)

Figure 7. India Varicella Vaccine Sales 2018-2029 (M Doses)

Figure 8. India Varicella Vaccine Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Varicella Vaccine Market Share in Global, in Volume (M Doses) 2018-2029

Figure 10. Varicella Vaccine Report Years Considered

Figure 11. Product Picture of Injection

Figure 12. Product Picture of Freeze-Dried Powder

Figure 13. Global Varicella Vaccine Market Share by Type in 2022 & 2029

Figure 14. Global Varicella Vaccine Sales in Value by Type (2018-2029) & (US$ Million)

Figure 15. Global Varicella Vaccine Sales Market Share in Value by Type (2018-2029)

Figure 16. Global Varicella Vaccine Sales by Type (2018-2029) & (M Doses)

Figure 17. Global Varicella Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 18. Global Varicella Vaccine Price by Type (2018-2029) & (USD/Dose)

Figure 19. India Varicella Vaccine Market Share by Type in 2022 & 2029

Figure 20. India Varicella Vaccine Sales in Value by Type (2018-2029) & (US$ Million)

Figure 21. India Varicella Vaccine Sales Market Share in Value by Type (2018-2029)

Figure 22. India Varicella Vaccine Sales by Type (2018-2029) & (M Doses)

Figure 23. India Varicella Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 24. India Varicella Vaccine Price by Type (2018-2029) & (USD/Dose)

Figure 25. Product Picture of Kids Injection

Figure 26. Product Picture of Adults Injection

Figure 27. Global Varicella Vaccine Market Share by Application in 2022 & 2029

Figure 28. Global Varicella Vaccine Sales in Value by Application (2018-2029) & (US$ Million)

Figure 29. Global Varicella Vaccine Sales Market Share in Value by Application (2018-2029)

Figure 30. Global Varicella Vaccine Sales by Application (2018-2029) & (M Doses)

Figure 31. Global Varicella Vaccine Sales Market Share in Volume by Application (2018-2029)

Figure 32. Global Varicella Vaccine Price by Application (2018-2029) & (USD/Dose)

Figure 33. India Varicella Vaccine Market Share by Application in 2022 & 2029

Figure 34. India Varicella Vaccine Sales in Value by Application (2018-2029) & (US$ Million)

Figure 35. India Varicella Vaccine Sales Market Share in Value by Application (2018-2029)

Figure 36. India Varicella Vaccine Sales by Application (2018-2029) & (M Doses)

Figure 37. India Varicella Vaccine Sales Market Share in Volume by Application (2018-2029)

Figure 38. India Varicella Vaccine Price by Application (2018-2029) & (USD/Dose)

Figure 39. Americas Varicella Vaccine Sales in Volume Growth Rate 2018-2029 (M Doses)

Figure 40. Americas Varicella Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 41. Americas Varicella Vaccine Sales by Type (2018-2029) & (M Doses)

Figure 42. Americas Varicella Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 43. Americas Varicella Vaccine Sales by Application (2018-2029) & (M Doses)

Figure 44. Americas Varicella Vaccine Sales Market Share in Volume by Application (2018-2029)

Figure 45. United States Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 46. Canada Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 47. Mexico Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Brazil Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. EMEA Varicella Vaccine Sales in Volume Growth Rate 2018-2029 (M Doses)

Figure 50. EMEA Varicella Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 51. EMEA Varicella Vaccine Sales by Type (2018-2029) & (M Doses)

Figure 52. EMEA Varicella Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 53. EMEA Varicella Vaccine Sales by Application (2018-2029) & (M Doses)

Figure 54. EMEA Varicella Vaccine Sales Market Share in Volume by Application (2018-2029)

Figure 55. Europe Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 56. Middle East Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 57. Africa Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. China Varicella Vaccine Sales in Volume Growth Rate 2018-2029 (M Doses)

Figure 59. China Varicella Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 60. China Varicella Vaccine Sales by Type (2018-2029) & (M Doses)

Figure 61. China Varicella Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 62. China Varicella Vaccine Sales by Application (2018-2029) & (M Doses)

Figure 63. China Varicella Vaccine Sales Market Share in Volume by Application (2018-2029)

Figure 64. APAC Varicella Vaccine Sales in Volume Growth Rate 2018-2029 (M Doses)

Figure 65. APAC Varicella Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 66. APAC Varicella Vaccine Sales by Type (2018-2029) & (M Doses)

Figure 67. APAC Varicella Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 68. APAC Varicella Vaccine Sales by Application (2018-2029) & (M Doses)

Figure 69. APAC Varicella Vaccine Sales Market Share in Volume by Application (2018-2029)

Figure 70. Japan Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 71. South Korea Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 72. China Taiwan Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. Southeast Asia Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. India Varicella Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. Varicella Vaccine Value Chain

Figure 76. Varicella Vaccine Production Process

Figure 77. Channels of Distribution

Figure 78. Distributors Profiles

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions